SENTI-202
SENTI-202-101
Phase 1 mab active
Quick answer
SENTI-202 for AML/MDS is a Phase 1 program (mab) at Senti Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Senti Biosciences Holdings
- Indication
- AML/MDS
- Phase
- Phase 1
- Modality
- mab
- Status
- active